Literature DB >> 678602

Particulate and free hexokinase in fetal rat liver.

F A Hommes, R S Everts.   

Abstract

The association of hexokinase with particulate fractions of liver has been studied during the development of the rat. In the fetal rat liver about 50% of the total hexokinase is bound to the mitochondria. This proportion decreases gradually after birth. No association of hexokinase with mitochondria could be demonstrated in the adult rat liver. It is suggested that the binding of hexokinase to the mitochondria is a consequence of a property which is lost during development of the mitochondrial membranes. At least part of the hexokinase is rather tightly bound to the mitochondria. Glucose-6-phosphate or ATP do not solubilize the enzyme. The proportion of hexokinase bound to the mitochondria is independent of the metabolic state of the hepatocyte as exemplified by studies with inhibitors of oxidative phosphorylation, using the digitonin technique for the separation of particulate and cytosol fractions of isolated fetal rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 678602     DOI: 10.1159/000241072

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  4 in total

1.  All hexokinase isoenzymes coexist in rat hepatocytes.

Authors:  A Reyes; M L Cárdenas
Journal:  Biochem J       Date:  1984-07-15       Impact factor: 3.857

2.  The transport and accumulation of adenine nucleotides during mitochondrial biogenesis.

Authors:  J K Pollak; R Sutton
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

Review 3.  The metabolic advantage of tumor cells.

Authors:  Maurice Israël; Laurent Schwartz
Journal:  Mol Cancer       Date:  2011-06-07       Impact factor: 27.401

Review 4.  Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses.

Authors:  Joanna Obacz; Silvia Pastorekova; Borek Vojtesek; Roman Hrstka
Journal:  Mol Cancer       Date:  2013-08-14       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.